We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
Isis Outcomes will be represented at the ISPOR 20th Annual International Meeting to be held in Philadelphia, from May 16th – 20th, 2015. In the conference Isis Outcomes will be presenting an electronic version of the Parkinson’s Disease Questionnaire (PDQ-39).
Isis Outcomes will be presenting on two recent collaborative ePRO activities at this event in Amsterdam 8th – 12th November 2014. In association with Professor Crispin Jenkinson and colleagues at the University of Oxford, PharmaQuest Ltd and CRF Health, Isis Outcomes will explain where it has supported the development of ePRO versions of its portfolio of health outcomes instruments.
The eCOA Forum brings together world leaders in PRO development and health outcomes.
A new health outcomes questionnaire for the measurement of health-related quality of life.
As the technology commercialisation company of Oxford University, Oxford University Innovation, celebrates its 25th anniversary, it also looks back on 101 companies that originate from Isis. Oxford Biotrans, the 101st company, will commercialise new routes to high-value chemicals using patented enzyme technology.
Oxford University Innovation, the University of Oxford’s technology transfer company, in partnership with ERT and PharmaQuest have developed an electronic questionnaire to better understand a condition that affects 10% of women. Endometriosis is a chronic, painful gynaecological condition that typically affects women of reproductive age and can lead to infertility. The questionnaire gauges the success of current endometriosis treatments as well as the impact on patient quality-of-life.
Sixteen new language versions have been completed by Oxford Outcomes Ltd, a research agency specialising in the translation and linguistic validation of patient reported outcome (PRO) measures.
Isis Outcomes will be exhibiting at the ISPOR 16th Annual International Meeting to be held in Baltimore, from May 21st - 25th 2011. The Health Outcomes business at Oxford University Innovation, Isis Outcomes, offers a growing selection of Patient-Reported Outcome measures (PROs) to global healthcare clients, for conditions such as Parkinson’s, Endometriosis, Orthopaedics and Motor Neurone Disease/Amyotrophic Lateral Sclerosis (ALS).